Global Strontium Ranelate Market Growth 2023-2029

Global Strontium Ranelate Market Growth 2023-2029

As an Anti osteoporosis drugs, Strontium Ranelate is mainly used for the treatment and prevention of postmenopausal women with osteoporosis, significantly reduce the risk of vertebral fractures and hip fractures.

Drug interactions of Strontium Ranelate:



Food, milk, dairy products and calcium containing preparations can reduce the bioavailability of strontium ranelate by 60% ~ 70%. Therefore, strontium ranelate should be taken with these substances at an interval of more than 2 hours. Since divalent cations can combine with oral tetracycline and quinolone antibiotics in the gastrointestinal tract to form complexes, thus reducing their absorption, strontium ranelate should not be taken with these drugs. As a precaution, strontium ranelate should be stopped when taking tetracycline and quinolones orally.

LPI (LP Information)' newest research report, the “Strontium Ranelate Industry Forecast” looks at past sales and reviews total world Strontium Ranelate sales in 2022, providing a comprehensive analysis by region and market sector of projected Strontium Ranelate sales for 2023 through 2029. With Strontium Ranelate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Strontium Ranelate industry.

This Insight Report provides a comprehensive analysis of the global Strontium Ranelate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Strontium Ranelate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Strontium Ranelate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Strontium Ranelate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Strontium Ranelate.

The global Strontium Ranelate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Strontium Ranelate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Strontium Ranelate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Strontium Ranelate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Strontium Ranelate players cover AbMole BioScience, American Elements, BioCrick BioTech, Combi-Blocks Inc, Fengchen Group, Hefei Home Sunshine Pharmaceutical Technology, Pharmaffiliates and Watson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Strontium Ranelate market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Purity 98%
Purity 99%

Segmentation by application
Medicine
Chemical
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbMole BioScience
American Elements
BioCrick BioTech
Combi-Blocks Inc
Fengchen Group
Hefei Home Sunshine Pharmaceutical Technology
Pharmaffiliates
Watson

Key Questions Addressed in this Report

What is the 10-year outlook for the global Strontium Ranelate market?

What factors are driving Strontium Ranelate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Strontium Ranelate market opportunities vary by end market size?

How does Strontium Ranelate break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.